GlobeNewswire Inc | Dec 20, 2021 04:05PM EST

December 20, 2021

BURLINGTON, Mass., Dec. 20, 2021 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, will participate virtually in two upcoming investor conferences.

Events:

11th Annual LifeSci Partners Corporate Access Event 2022Wednesday, January 5 Friday, January 7Registration and to submit 1x1 meeting requests: LifeSci Partners Corporate Access Event 2022

H.C. Wainwright Virtual BioConnect 2022 ConferenceMonday, January 10 Thursday, January 13A webcast of Mr. Tuckers presentation will be available on-demand as of 7am EST, Monday, January 10.

A replay of the presentation can be accessed under News & Events in the Investor Relations section of the Companys website, www.scpharmaceuticals.com.

About scPharmaceuticals scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Companys lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine TaudvinscPharmaceuticals Inc., 781-301-6706ktaudvin@scpharma.com

Investors:Hans VitzthumLifeSci Advisors, 617-430-7578hans@lifesciadvisors.com